Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadriderme in Impetiginous Eczema
NCT00671528Phase 4Terminated
- Sponsor
- Organon & Co.
- Start
- Jul 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of betamethasone dipropionate + clotrimazole + gentamicin in Eczema (3 arms), sponsored by Organon & Co. Primary endpoint: Percent Improvement of Individually Measured Signs of the Disease at Day 28. Started Jul 2009; status: terminated.
02
Drugs
betamethasone dipropionate + clotrimazole + gentamicin
03
Conditions
Eczema
Beyond the preview
Go deeper on NCT00671528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671528.